Lovastatin clinical trials cholesterol lowering intervention

Mevacor - MK803 - MK 803 - MK-803 - 6 Methylcompactin - 6-Methylcompactin - Monacolin K - Mevinolin - Lovastatin

Cardiovascular prevention

All chronical situations:  10 trials  - CLAPT - AFCAPS/TexCAPS - ACAPS - CCAIT - CRISP 20mg - CRISP 40mg - Weintraub - MARS - Excel - Sahni

Diabetic patients:  2 trials  - CRISP 20mg - CRISP 40mg

Elderly:  1 trials  - CRISP 20mg

Patients with LDL elevation and without CHD:  1 trials  - AFCAPS/TexCAPS

Patients with other atherosclerotic localisation:  1 trials  - ACAPS

Patients with prior MI or with CHD:  2 trials  - CLAPT - Sahni

Primary prevention:  2 trials  - AFCAPS/TexCAPS - ACAPS

Secondary prevention:  7 trials  - CLAPT - AFCAPS/TexCAPS - ACAPS - CCAIT - Weintraub - MARS - Sahni

Women:  1 trials  - AFCAPS (women subgroup)

Diabetes type 2

Diabetic patients with or withour hypercholesterolemia:  1 trials  - AFCAPS/TexCAPS (diabetic sub group)

Primary prevention:  1 trials  - AFCAPS/TexCAPS (diabetic sub group)

Percutaneous coronary intervention

Peripheral vascular diseases